Latest stories on BLFS
BLFS Faces Shareholder Scrutiny as Sale Terms Questioned: Are Ordinary Holders Getting a Fair Deal?
July 28, 2026
MarketChameleon38 · neutralgeneral
Canaccord reiterates Hold on Repligen stock after BioLife deal
Investing.com Analyst Ratings50 · neutralm&a
TD Cowen downgrades BioLife Solutions stock rating on Repligen deal
Investing.com Analyst Ratings34 · bearishanalyst
BIOLIFE SOLUTIONS INC (BLFS) files 8-K
SEC 8-K50 · neutralgeneral
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach
Yahoo Top68 · bullishm&a
BLFS Merger Faces Scrutiny as Halper Sadeh LLC Investigates Deal Price for Shareholders
MarketChameleon38 · neutralm&a
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife
Investing.com Markets63 · neutralm&a
Repligen to Acquire BioLife, Expanding Cell Therapy Reach
TipRanks63 · neutralm&a
Repligen’s $1.5B BioLife Acquisition Poised to Reshape Cell Therapy Market with Accretive Growth
July 22, 2026
MarketChameleon73 · bullishm&a
Repligen's $1.5 Billion BioLife Acquisition Boosts Cell Therapy Market Presence and Earnings Outlook
MarketChameleon73 · bullishm&a
Repligen to buy BioLife in $1.5 billion deal to expand cell therapy business
Yahoo Finance68 · bullishm&a
Repligen to buy BioLife Solutions in $1.5 billion deal
Reuters63 · neutralm&a
Repligen to buy BioLife Solutions in $1.5B stock-and-cash deal
Seeking Alpha68 · bullishm&a
BioLife is said to have drawn takeover interest from Repligen
Seeking Alpha63 · neutralm&a
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?
Yahoo Top57 · neutralgeneral
BioLife Highlights Strategy Shift in New Investor Presentation
TipRanks56 · neutralgeneral
Orthofix Medical and 5 More Stocks See Activist Action
Barron's55 · neutralgeneral
BioLife Solutions Q1 Earnings Call Highlights
Yahoo Top63 · neutralearnings
BioLife Solutions Reports First Quarter 2026 Financial Results
PR Newswire63 · neutralearnings